297 related articles for article (PubMed ID: 17098353)
1. Survival and prognostic classification of patients with metastatic renal cell carcinoma of bone.
Toyoda Y; Shinohara N; Harabayashi T; Abe T; Akino T; Sazawa A; Nonomura K
Eur Urol; 2007 Jul; 52(1):163-8. PubMed ID: 17098353
[TBL] [Abstract][Full Text] [Related]
2. Prognostic factors of metastatic renal cell carcinoma after failure of immunotherapy: new paradigm from a large phase III trial with shark cartilage extract AE 941.
Escudier B; Choueiri TK; Oudard S; Szczylik C; Négrier S; Ravaud A; Chevreau C; Venner P; Champagne P; Croteau D; Dupont E; Hariton C; Bukowski RM
J Urol; 2007 Nov; 178(5):1901-5. PubMed ID: 17868728
[TBL] [Abstract][Full Text] [Related]
3. Prognostic factors for survival in previously treated patients with metastatic renal cell carcinoma.
Motzer RJ; Bacik J; Schwartz LH; Reuter V; Russo P; Marion S; Mazumdar M
J Clin Oncol; 2004 Feb; 22(3):454-63. PubMed ID: 14752067
[TBL] [Abstract][Full Text] [Related]
4. Prognostic relevance of tumour size in T3a renal cell carcinoma: a multicentre experience.
Lam JS; Klatte T; Patard JJ; Goel RH; Guillè F; Lobel B; Abbou CC; De La Taille A; Tostain J; Cindolo L; Altieri V; Ficarra V; Artibani W; Prayer-Galetti T; Schips L; Zigeuner R; Pantuck AJ; Figlin RA; Belldegrun AS
Eur Urol; 2007 Jul; 52(1):155-62. PubMed ID: 17316970
[TBL] [Abstract][Full Text] [Related]
5. Cytoreductive nephrectomy for metastatic renal cell carcinoma with nonclear cell histology.
Kassouf W; Sanchez-Ortiz R; Tamboli P; Tannir N; Jonasch E; Merchant MM; Matin S; Swanson DA; Wood CG
J Urol; 2007 Nov; 178(5):1896-900. PubMed ID: 17868729
[TBL] [Abstract][Full Text] [Related]
6. Prognostic factors for survival in patients with brain metastases from renal cell carcinoma.
Culine S; Bekradda M; Kramar A; Rey A; Escudier B; Droz JP
Cancer; 1998 Dec; 83(12):2548-53. PubMed ID: 9874462
[TBL] [Abstract][Full Text] [Related]
7. Renal sinus fat invasion in pT3a clear cell renal cell carcinoma affects outcomes of patients without nodal involvement or distant metastases.
Bertini R; Roscigno M; Freschi M; Strada E; Petralia G; Pasta A; Matloob R; Sozzi F; Da Pozzo L; Colombo R; Guazzoni G; Doglioni C; Montorsi F; Rigatti P
J Urol; 2009 May; 181(5):2027-32. PubMed ID: 19286201
[TBL] [Abstract][Full Text] [Related]
8. Sarcomatoid differentiation as a prognostic factor for immunotherapy in metastatic renal cell carcinoma.
Kwak C; Park YH; Jeong CW; Jeong H; Lee SE; Moon KC; Ku JH
J Surg Oncol; 2007 Mar; 95(4):317-23. PubMed ID: 17066434
[TBL] [Abstract][Full Text] [Related]
9. Prognostic factors for survival in patients with metastatic renal cancer treated with biological response modifiers.
Mani S; Todd MB; Katz K; Poo WJ
J Urol; 1995 Jul; 154(1):35-40. PubMed ID: 7539867
[TBL] [Abstract][Full Text] [Related]
10. Treatment of osseous metastases in patients with renal cell carcinoma.
Jung ST; Ghert MA; Harrelson JM; Scully SP
Clin Orthop Relat Res; 2003 Apr; (409):223-31. PubMed ID: 12671506
[TBL] [Abstract][Full Text] [Related]
11. Prognostic factors and survival after pulmonary resection of metastatic renal cell carcinoma.
Hofmann HS; Neef H; Krohe K; Andreev P; Silber RE
Eur Urol; 2005 Jul; 48(1):77-81; discussion 81-2. PubMed ID: 15967255
[TBL] [Abstract][Full Text] [Related]
12. Location of extrarenal tumor extension does not impact survival of patients with pT3a renal cell carcinoma.
Margulis V; Tamboli P; Matin SF; Meisner M; Swanson DA; Wood CG
J Urol; 2007 Nov; 178(5):1878-82. PubMed ID: 17868733
[TBL] [Abstract][Full Text] [Related]
13. Preoperative prognostic nomogram (probability table) for renal cell carcinoma based on TNM classification.
Kanao K; Mizuno R; Kikuchi E; Miyajima A; Nakagawa K; Ohigashi T; Nakashima J; Oya M
J Urol; 2009 Feb; 181(2):480-5; discussion 485. PubMed ID: 19100568
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of renal vein and inferior vena cava involvement in renal cell carcinoma.
Wagner B; Patard JJ; Méjean A; Bensalah K; Verhoest G; Zigeuner R; Ficarra V; Tostain J; Mulders P; Chautard D; Descotes JL; de la Taille A; Salomon L; Prayer-Galetti T; Cindolo L; Valéri A; Meyer N; Jacqmin D; Lang H
Eur Urol; 2009 Feb; 55(2):452-9. PubMed ID: 18692951
[TBL] [Abstract][Full Text] [Related]
15. Prognostic factors and surgical treatment of osseous metastases secondary to renal cell carcinoma.
Althausen P; Althausen A; Jennings LC; Mankin HJ
Cancer; 1997 Sep; 80(6):1103-9. PubMed ID: 9305711
[TBL] [Abstract][Full Text] [Related]
16. External validation of the Mayo Clinic cancer specific survival score in a Japanese series of clear cell renal cell carcinoma.
Fujii Y; Saito K; Iimura Y; Sakai Y; Koga F; Kawakami S; Kumagai J; Kihara K
J Urol; 2008 Oct; 180(4):1290-5; discussion 1295-6. PubMed ID: 18707704
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of perinephric fat infiltration and tumor size in renal cell carcinoma.
Yoo C; Song C; Hong JH; Kim CS; Ahn H
J Urol; 2008 Aug; 180(2):486-91; discussion 491. PubMed ID: 18550101
[TBL] [Abstract][Full Text] [Related]
18. Impact of macroscopic tumour necrosis to predict survival of patients with surgically resected renal cell carcinoma.
Pflanz S; Brookman-Amissah S; Roigas J; Kendel F; Hoschke B; May M
Scand J Urol Nephrol; 2008; 42(6):507-13. PubMed ID: 19031267
[TBL] [Abstract][Full Text] [Related]
19. External validation of an international multicenter study to predict survival in Korean patients with pT2N0M0 renal cell carcinoma.
Ku JH; Moon KC; Kwak C; Kim HH
Urology; 2009 Aug; 74(2):359-63. PubMed ID: 19501879
[TBL] [Abstract][Full Text] [Related]
20. Impact of immune parameters on long-term survival in metastatic renal cell carcinoma.
Donskov F; von der Maase H
J Clin Oncol; 2006 May; 24(13):1997-2005. PubMed ID: 16648500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]